US Stock MarketDetailed Quotes
ADGM Adagio Medical
- 2.300
- -0.170-6.88%
Close Dec 4 16:00 ET
- 2.250
- -0.050-2.17%
Post 19:34 ET
33.43MMarket Cap-771P/E (TTM)
2.400High2.260Low41.35KVolume2.400Open2.470Pre Close95.80KTurnover1.33%Turnover RatioLossP/E (Static)14.54MShares11.57052wk High0.44P/B7.15MFloat Cap1.69052wk Low--Dividend TTM3.11MShs Float12.380Historical High--Div YieldTTM5.67%Amplitude1.690Historical Low2.316Avg Price1Lot Size
About Adagio Medical Company
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.
Company Profile
SymbolADGM
Company NameAdagio Medical
Listing DateFeb 26, 2021
Founded2020
CEOMr. Olav B. Bergheim
MarketNASDAQ
Fiscal Year Ends12-31
Address51 Astor Place,10th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10003
Phone1-212-284-2300
Company Executives
- Name
- Position
- Salary
- Olav B. Bergheim
- Chief Executive Officer and Chairman of the Board
- --
- John T. Dahldorf
- Chief Financial Officer
- --
- Hakon Bergheim
- Chief Operating Officer
- --
- Timothy P. Moran
- Independent Director
- --
- Shahram Moaddeb
- Independent Director
- --
- Sandra A. Gardiner
- Independent Director
- --
- Orly Mishan
- Independent Director
- --
- Dr. Keyvan Mirsaeedi-Farahani, M.D.
- Independent Director
- --
- Dr. James L. Cox, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data